Keith Johns Joins Allurion’s Board of Directors

Allurion Technologies Inc. has appointed Keith Johns to its Board of Directors.
 
“We are extremely excited to welcome Keith to the Allurion Board of Directors as we look to capitalize on the significant opportunity in front of us within the fast-growing obesity management space,” Allurion Founder/CEO Dr. Shantanu Gaur stated. “I believe having Keith as a sounding board as we leverage the opportunities created by GLP-1s will be a competitive advantage.”
 
“Keith is a fantastic addition and brings a new point of view to our board. His more than two decades at Eli Lilly provide him with a unique perspective on the obesity market, specifically on new product launches, reimbursement dynamics, and strategic partnerships,” Former Medtronic Chairman/CEO and Allurion Co-Chairman Omar Ishrak added.
 
Johns worked for nearly 25 years at Eli Lilly, holding many senior leadership positions, most recently as head of Global Marketing and Alliance Management for Eli Lilly’s Diabetes and Obesity Business Unit. After retiring from Eli Lilly, Johns became the chief operating officer at Adipo Therapeutics, a company on the cutting edge of harnessing the power of brown adipose tissue to advance the treatment of obesity and related metabolic disorders.
 
“I am thrilled to join Allurion’s Board of Directors at this exciting time, not only in Allurion’s journey to become a leading provider of weight loss therapies but also in the obesity management space generally, which continues to show explosive growth and opportunity due to the significant unmet needs of both people with obesity and health care providers,” Johns said.
 
Allurion is dedicated to ending obesity. The Allurion Program is a weight loss platform that features the Allurion Gastric Balloon, the world’s first and only swallowable, procedure-less intragastric balloon for weight loss, and offers access to the Allurion Virtual Care Suite, including the Allurion Mobile App for consumers, Allurion Insights for health care providers featuring the Coach Iris AI Platform, and the Allurion Connected Scale. The Allurion Virtual Care Suite is also available to providers separately from the Allurion Program to help customize, monitor and manage weight loss therapy for patients regardless of their treatment plan: gastric balloon, surgical, medical or nutritional. The Allurion Gastric Balloon is an investigational device in the United States.